AxoGen, Inc. (NASDAQ:AXGN) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone. Joining me on today's call is Michael Dale, Axogen's Chief Executive Officer and Director; and Nir Naor, Chief Financial Officer.
Axogen Inc. (AXGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 3,005,943 | $42,143,321 | -10% | 3.26% |
| 2. | Millennium Management Israel Englander | 959,592 | $13,453,480 | +41% | 0% |
| 3. | DAFNA Capital Management Nathan Fischel | 935,894 | $13,121,234 | 3.09% | |
| 4. | D E Shaw D. E. Shaw | 634,344 | $8,893,503 | +5% | 0% |
| 5. | Parkman Healthcare Partners Greg Martinez | 412,888 | $5,788,690 | 0.73% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.22 | 10,000 | Director | 80,342 | 2023-09-06 | Filing | |
| $6.56 | 10,000 | Director | 10,000 | 2023-08-23 | Filing | |
| $6.11 | 10,000 | Director | 68,259 | 2023-08-16 | Filing | |
| $14.10 | 14,170 | Director | 15,535 | 2019-08-12 | Filing | |
| $13.07 | 200 | Director | 1,365 | 2019-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.68 | 3,166 | Officer, Director | 1,143,788 | 2024-03-21 | Filing | |
| $7.68 | 3,086 | Officer, Director | 1,133,979 | 2024-03-21 | Filing | |
| $7.68 | 33,028 | Officer, Director | 1,124,565 | 2024-03-21 | Filing | |
| $7.68 | 3,141 | Officer | 177,474 | 2024-03-21 | Filing | |
| $7.68 | 721 | Officer | 167,890 | 2024-03-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,152,300 | $35,190,209 | 0.38% | |
| 2. | 3,342,773 | $22,831,140 | 0% | |
| 3. | 3,082,437 | $21,053,045 | 0% | |
| 4. | 2,465,496 | $16,839,338 | 0% | |
| 5. | 896,336 | $6,122,669 | 0% |
News See All
AxoGen, Inc. (NASDAQ:AXGN) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. Reports 2024 Second Quarter Financial Results Call. At this time all participants are in a listen-only mode.
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. 2024 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
AxoGen, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09.
AxoGen, Inc. (NASDAQ:AXGN) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the AxoGen Reports Third Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode.
AxoGen, Inc. (NASDAQ:AXGN) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the AxoGen, Inc. Reports Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
AxoGen, Inc. (NASDAQ:AXGN) Q1 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen. And welcome to the AxoGen Incorporated Reports First Quarter 2023 Financial Results.
AxoGen, Inc. (NASDAQ:AXGN) Q4 2022 Earnings Call Transcript
Operator: Welcome to the AxoGen Fourth Quarter 2022 Conference Call. As a reminder, this conference is being recorded.
Is AXGN A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Is AxoGen, Inc. (AXGN) Going to Burn These Hedge Funds?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.